Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
https://link.springer.com/content/pdf/10.1007/s00345-020-03474-8.pdf
Reference46 articles.
1. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7–30. https://doi.org/10.3322/caac.21590
2. Meeks JJ, Lerner SP (2017) Molecular landscape of non-muscle invasive bladder cancer. Cancer Cell 32:550–551. https://doi.org/10.1016/j.ccell.2017.08.015
3. Sylvester RJ et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466–465. https://doi.org/10.1016/j.eururo.2005.12.031(Discussion 475–467)
4. Babjuk M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447–461. https://doi.org/10.1016/j.eururo.2016.05.041
5. Roupret M et al (2016) CCAFU french national guidelines 2016–2018 on bladder cancer. Prog Urol 27(Suppl 1):S67–S91. https://doi.org/10.1016/S1166-7087(16)30704-7
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment Strategies for BCG Unresponsive Non-muscle Invasive Bladder Cancer;annals of urologic oncology;2024-08-29
2. Basement membrane-related MMP14 predicts poor prognosis and response to immunotherapy in bladder cancer;BMC Cancer;2024-06-19
3. Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature;BMC Urology;2024-03-26
4. Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database;Urologic Oncology: Seminars and Original Investigations;2024-03
5. Immunotherapeutic prospects and progress in bladder cancer;Journal of Cellular and Molecular Medicine;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3